Sahin, Eda AdeviyeToprak, SerhatSayal, Hasan BerkanEkinci, TekinYilmaz, ErcanBakay, KadirMelekoglu, Rauf2024-08-042024-08-0420220020-72921879-3479https://doi.org/10.1002/ijgo.14277https://hdl.handle.net/11616/100727Objective To investigate the prognostic factors of patients with Grade 3 endometrioid endometrial cancer (G3EEC). Methods This four-center, retrospective study included a total of 129 women with G3EEC. Demographic, clinicopathologic, and survival data were collected. Kaplan-Meier method was used for survival analysis. Predictors of outcome were analyzed using Cox proportional hazards models. Results Median age at the time of diagnosis was 63 (range 39-87) years and median follow up was 37 (range 6-126) months. For the entire cohort, the 5-year disease-free survival (DFS) and overall survival (OS) were 54.3% and 63.6%, respectively. The 5-year DFS rates for lymphovascular space invasion (LVSI) -positive and -negative patients were 41.6% and 88.3%, respectively (P < 0.001). The 5-year OS rates for LVSI-positive and -negative patients were 54.7% and 88.3%, respectively (P = 0.001). Positive LVSI status was identified as the independent prognostic factor for decreased DFS and OS (hazard ratio [HR] 5.5, 95% confidence interval [CI] 1.65-18.86; P = 0.006 versus HR 4.4, 95% CI 1.33-14.58; P = 0.013, respectively). Conclusion LVSI seems to be an independent prognostic factor for decreased DFS and OS in G3EEC patients.eninfo:eu-repo/semantics/closedAccessendometrial cancerGrade3prognostic factorArticle15937197263559815310.1002/ijgo.142772-s2.0-85132356012Q1WOS:000814277800001Q2